Clinical Trials
130 trialsFollow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
National Institutes of Health Clinical Center (CC)
PRO-NEM1
Centre Hospitalier Universitaire Dijon
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
iCaRe2
University of Nebraska
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
REAL-LU
Novartis
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Ipsen
Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study
West China Hospital
PRRT
Methodist Health System
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
Huazhong University of Science and Technology
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
University of California, Davis
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center
CardioNETPOL
National Institute of Cardiology, Warsaw, Poland
TNE-bien-DIF
Assistance Publique - Hôpitaux de Paris
FARINET
IRCCS San Raffaele
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
First Affiliated Hospital of Zhejiang University
DENUTNE
University Hospital, Strasbourg, France
SALUS
Advanced Accelerator Applications
NET-PRO
University of Iowa
ETP-NET
Hospices Civils de Lyon
RegisterNET
Wren Laboratories LLC
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
National Institutes of Health Clinical Center (CC)
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
GAPET-NET
University Hospital, Brest
AURA-RIV-TNE
Hospices Civils de Lyon
GEP-NENs
Tongji Hospital
TAILOR-EUS
IRCCS San Raffaele
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Nanjing First Hospital, Nanjing Medical University
REBORN
University of Roma La Sapienza
NUTRIGETNE
Grupo Espanol de Tumores Neuroendocrinos
ANZ UGI
Western Sydney Local Health District
A Transfer Learning Radiomics Model for Predicting Response to Initial Transarterial Embolization in Patients with Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases
First Affiliated Hospital, Sun Yat-Sen University
JPET2Clinic
Jagiellonian University
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
Latin American Cooperative Oncology Group
TEGRELE
Central Hospital, Nancy, France
NETAT
University of Pennsylvania
NEMESIs
University Hospital, Basel, Switzerland
AIM-NETs
Asan Medical Center
EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms
European Institute of Oncology
ECHO-NET
Istituto Clinico Humanitas
ROOT
Taproot Health
PREF-NET
Ipsen
PitNET2024
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
Fujian Maternity and Child Health Hospital
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Universidad Nacional Autonoma de Mexico
RELAX
TerSera Therapeutics LLC
ETNA-FPG
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
BANN
University Medical Center Groningen
VIDEO-NET
University Medical Center Groningen